Document Detail

Treatment of symptomatic congenital cytomegalovirus infection beyond the neonatal period.
MedLine Citation:
PMID:  22750017     Owner:  NLM     Status:  Publisher    
BACKGROUND: Congenital cytomegalovirus (CMV) is an important cause of sensorineural hearing loss. Ganciclovir treatment in the neonatal period may prevent hearing deterioration in infants with central nervous system (CNS) involvement. However, there are hardly any data regarding antiviral treatment begun beyond the neonatal period. OBJECTIVES: To describe the hearing outcome of infants with congenital CMV infection and CNS involvement treated beyond the neonatal period. To assess the tolerability and toxicity of prolonged valganciclovir treatment in these patients. STUDY DESIGN: Retrospective case series of infants with congenital CMV infection and CNS involvement who started antiviral treatment beyond the neonatal period in Spain between 2008 and 2010. Hearing was tested by brainstem-evoked response at the time of diagnosis, 6 and 12 months after the beginning of treatment. RESULTS: Thirteen cases were included. All received oral valganciclovir, and 4 also intravenous ganciclovir. Median valganciclovir treatment duration was 6 months and it was well tolerated. Six patients developed neutropenia, none requiring granulocyte colony-stimulating factor. Eleven children (85%) had hearing defects at baseline, compared to 50% at 12 months. By ears, 18 ears showed hearing loss at baseline (7 mild, 3 moderate, 8 severe). At 12 months, 9 remained stable, 7 had improved and none had worsened. In 8 normal ears at baseline, no deterioration was found at 12 months. CONCLUSIONS: Valganciclovir treatment is well tolerated. It may improve or preserve the auditory function of congenitally cytomegalovirus-infected patients treated beyond the neonatal period for at least one year after the beginning of antiviral treatment.
Teresa Del Rosal; Fernando Baquero-Artigao; Daniel Blázquez; Antoni Noguera-Julian; David Moreno-Pérez; Alejandro Reyes; Javier Vilas
Related Documents :
22922527 - Cost-effectiveness analysis of preventing mother-to-child transmission of hepatitis b b...
21448207 - Improved outcomes with a standardized feeding protocol for very low birth weight infants.
22750017 - Treatment of symptomatic congenital cytomegalovirus infection beyond the neonatal period.
11882727 - The risk of major birth defects after intracytoplasmic sperm injection and in vitro fer...
11332167 - Antenatal magnesium sulphate exposure is associated with prolonged parathyroid hormone ...
21430237 - Infant feeding options, other nonchemoprophylactic factors and mother-to-child transmis...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-6-30
Journal Detail:
Title:  Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology     Volume:  -     ISSN:  1873-5967     ISO Abbreviation:  -     Publication Date:  2012 Jun 
Date Detail:
Created Date:  2012-7-3     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9815671     Medline TA:  J Clin Virol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2012 Elsevier B.V. All rights reserved.
Department of Pediatrics, Hospital La Paz, Paseo de la Castellana 268, 28046 Madrid, Spain.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Postural sway as a marker of progression in Parkinson's disease: a pilot longitudinal study.
Next Document:  Epidemiology of varicella in Mexico.